RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy - Wikidata - awgldk - TriplyDB

RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy

RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy

http://www.wikidata.org/entity/Q34634649

about

Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.Metastasis suppressors in breast cancers: mechanistic insights and clinical potential HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2 RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells.Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway.Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer.Metastasis suppressors: functional pathways.Phosphatidylethanolamine binding protein 1 in vacular endothelial cell autophagy and atherosclerosis.Role of pepsin and pepsinogen: linking laryngopharyngeal reflux with otitis media with effusion in children.Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.Targeting Raf Kinase Inhibitory Protein Regulation and Function

P2860

Q27000441-47AAFA11-E800-4520-AF75-8ED559235361 Q34151444-60B3A681-EA07-4347-8720-2DC44913E668 Q36782534-B1235E33-1B76-4EA7-ACDF-F3769918BE8B Q36998275-A4DEAC4C-256E-4C4E-9C9C-FD212E065343 Q37564738-05E4959C-78FC-4FC1-BA7B-FB25B4F64FE5 Q37582063-1B979EA8-4A6F-4BD3-A87A-1E5F8C85689C Q37668572-F384B2A5-6A2B-4DF0-857A-9C197F0399D1 Q37683039-71F46CF1-4253-4836-95A3-B1D051770F55 Q38322277-A8D9D00E-9333-4703-B7B4-3C091EE051B7 Q38924621-687ECFA3-C4F1-4A9F-A550-CAC1AE079DE2 Q39045296-2C4128BF-ABA3-4475-A357-77133BD23999 Q39161075-7AB83E6A-C022-449B-8D20-D183CD865C9A Q39221235-9290CD93-3B54-4944-8690-6357FAB50D60 Q47097935-AA70540C-1170-4162-934E-08608B9218C7 Q47716769-E6A4A689-AB0B-48FE-9695-9FE2FDA46544 Q47743085-11DD290A-CD4A-4A8F-925B-743DFC0EF429 Q54233976-78CD8D82-844C-484F-9BD4-0B3E44D01584 Q55028849-932FF0DB-B2F8-4A90-B7E4-B1406BE94961 Q58764292-2D30893E-9831-4EB7-B44D-7D725EB69E66

P2860

RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy

http://www.wikidata.org/entity/Q34634649

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@ast

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@en

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@nl

type

label

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@ast

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@en

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@nl

prefLabel

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@ast

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@en

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@nl

P1433

Q34634649-6503D7E0-ED6F-4CD4-85AE-654EBF463624

P1476

Q34634649-1FD90D86-C36D-4F01-89AD-DF2E69DB4857

P2093

Q34634649-7391C9D7-DD1C-476C-A312-58CA745E2DF0

Q34634649-9D534EF5-9D33-4223-A401-69F4867EDBE4

Q34634649-BC765F7F-3A82-4935-8B57-AB65B4986E81

Q34634649-F9661833-840B-431E-A399-A7878C2EB417

P2860

Q34634649-083B63A4-60D7-4200-9DD1-83A97AB88B13

Q34634649-0BCE48E9-2351-453B-9715-D808499D0C37

Q34634649-0C073916-D2C6-4D7D-9262-04772E3E4065

Q34634649-0EC838E0-6E26-4702-8C18-D1661C8BC87A

Q34634649-154844AF-D6A9-4ED0-98D9-5872FA161765

Q34634649-1758D7BC-F5E1-45B5-9292-D4CDF08CD03B

Q34634649-177CF4DB-029C-4939-BD55-6D08A948A67B

Q34634649-187BD328-0724-4B75-9864-6FBE83C728F8

Q34634649-32BB1256-5887-4D1C-890B-734F4C4FBEA0

Q34634649-3A07D8A6-4360-440F-B1A4-F8B5DDC96C1A

P304

Q34634649-82E60E13-96DA-4539-87F4-7F87DA0A2F1D

P31

Q34634649-979B02CF-6360-455B-BFCF-23695AB82ED7

P356

Q34634649-05556D13-CF50-458F-ACB2-6951F3DF5029

P407

Q34634649-861B26B9-72FD-42B4-BF73-B4F87A0BEE05

P433

Q34634649-7EAF892B-7DF1-4ED0-BAD1-EDB1CED424D5

P478

Q34634649-483E2155-0FED-45C0-8AD5-9726663ABA9D

P50

Q34634649-56676675-C616-4445-8D21-A4754ECFD615

Q34634649-617EB7E0-F28F-4A4D-93CC-034756009F12

Q34634649-6C617F06-BFEB-44E3-AAD5-54FC042C7EBF

Q34634649-84A145A4-EA47-4151-BA7A-54393E87D8A7

Q34634649-8F349C93-702A-4800-8002-C8D02F7B5F4A

Q34634649-DB5B7E63-2200-4EF4-B743-8A542AB41A9D

P577

Q34634649-A33DE19E-00C3-4B40-A0E1-241FDDCBDDD3

P5875

Q34634649-718C6145-972E-4006-89E5-D65B0FAC9970

P698

Q34634649-DA395E1D-322B-4D12-927A-C3E9EA30B9A0

P932

Q34634649-33548B81-BA5D-4E31-B232-79B3FAA9764A

P356

JOURNAL.PONE.0059104

P1433

P1476

RKIP inhibition in cervical ca ...... esistance to cisplatin therapy

@en

P2093

Celso di Loreto

http://www.w3.org/2001/XMLSchema#string

Luis F J Ribeiro

http://www.w3.org/2001/XMLSchema#string

Marise A R Moreira

http://www.w3.org/2001/XMLSchema#string

Marsha R Rosner

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation

Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP

Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration

A new model for raf kinase inhibitory protein induced chemotherapeutic resistance

Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation

Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint

Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2

P304

e59104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0059104

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Rui Manuel Reis

Adhemar Longatto-Filho

Vera Miranda-Gonçalves

P577

2013-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236078913

http://www.w3.org/2001/XMLSchema#string

P698

23527098

http://www.w3.org/2001/XMLSchema#string

P932

3602518

http://www.w3.org/2001/XMLSchema#string